Research progress on multiple cell death pathways of podocytes in diabetic kidney disease

被引:0
作者
Can Yang
Zhen Zhang
Jieting Liu
Peijian Chen
Jialing Li
Haiying Shu
Yanhui Chu
Luxin Li
机构
[1] Mudanjiang Medical University,Heilongjiang Key Laboratory of Anti
[2] Mudanjiang Medical University,Fibrosis Biotherapy
[3] Mudanjiang Medical University,College of Life Sciences
来源
Molecular Medicine | / 29卷
关键词
Diabetic kidney disease; Podocyte; Apoptosis; Autophagy; Endoplasmic reticulum stress; Pyroptosis; Necroptosis; Ferroptosis; Mitotic catastrophe;
D O I
暂无
中图分类号
学科分类号
摘要
Diabetic kidney disease (DKD) is the main cause of end-stage renal disease, and its clinical manifestations are progressive proteinuria, decreased glomerular filtration rate, and renal failure. The injury and death of glomerular podocytes are the keys to DKD. Currently, a variety of cell death modes have been identified in podocytes, including apoptosis, autophagy, endoplasmic reticulum (ER) stress, pyroptosis, necroptosis, ferroptosis, mitotic catastrophe, etc. The signaling pathways leading to these cell death processes are interconnected and can be activated simultaneously or in parallel. They are essential for cell survival and death that determine the fate of cells. With the deepening of the research on the mechanism of cell death, more and more researchers have devoted their attention to the underlying pathologic research and the drug therapy research of DKD. In this paper, we discussed the podocyte physiologic role and DKD processes. We also provide an overview of the types and specific mechanisms involved in each type of cell death in DKD, as well as related targeted therapy methods and drugs are reviewed. In the last part we discuss the complexity and potential crosstalk between various modes of cell death, which will help improve the understanding of podocyte death and lay a foundation for new and ideal targeted therapy strategies for DKD treatment in the future.
引用
收藏
相关论文
共 450 条
  • [91] Leppert U(2016)Non-canonical cell death induced by p53 Int J Mol Sci 17 663-116
  • [92] Erekat NS(2013)Vascular complications of diabetes: mechanisms of injury and protective factors Cell Metab 17 76-1634
  • [93] Erekat NS(2008)The podocyte and diabetes mellitus: is the podocyte the key to the origins of diabetic nephropathy? Curr Opin Nephrol Hypertens 17 14-245
  • [94] Erekat NS(2007)Proteinuria: is it all in the foot? J Clin Invest 117 10-59
  • [95] Fan Y(2016)Upregulation of α3β1-integrin in podocytes in early-stage diabetic nephropathy J Diabetes Res 2016 23-559
  • [96] Lee K(2015)Thioredoxin-interacting protein deficiency protects against diabetic nephropathy J Am Soc Nephrol 26 225-65
  • [97] Wang N(2021)Podocyte aging: why and how getting old matters J Am Soc Nephrol 32 3219-21
  • [98] He JC(2010)Regulation of podocyte survival and endoplasmic reticulum stress by fatty acids Am J Physiol Renal Physiol 299 347-1706
  • [99] Fan Y(2016)MicroRNAs in diabetic nephropathy: from biomarkers to therapy Curr Diab Rep 16 1513-381
  • [100] Zhang J(2022)Sestrin2 remedies podocyte injury via orchestrating TSP-1/TGF-β1/Smad3 axis in diabetic kidney disease Cell Death Dis 13 2195-undefined